Stay updated on Efgartigimod in ITP Clinical Trial
Sign up to get notified when there's something new on the Efgartigimod in ITP Clinical Trial page.

Latest updates to the Efgartigimod in ITP Clinical Trial page
- Check3 days agoChange DetectedThe displayed ClinicalTrials.gov site revision changed from v3.7.2 to v3.8.0; the study record content remains unchanged.SummaryDifference0.1%

- Check10 days agoChange DetectedA banner announces NIH website-transition updates and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference0.5%

- Check17 days agoChange DetectedThe site footer revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check24 days agoChange DetectedThe ClinicalTrials.gov footer revision changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page’s version log now lists Revision: v3.7.0 as the latest entry, replacing the previous Revision: v3.6.6, indicating an update to the page's underlying platform or template rather than to the study data.SummaryDifference0.1%

- Check66 days agoChange DetectedThe record history now includes a new revision entry (v3.6.6) and removes the previous v3.6.5 entry, indicating a latest version update to the page's metadata. This update affects only the versioning log and does not change trial data, eligibility, or results on the page.SummaryDifference0.1%

Stay in the know with updates to Efgartigimod in ITP Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efgartigimod in ITP Clinical Trial page.